Document is current

Any future updates will be listed below

Investigation of the Factors Affecting Risk-Based Quality Management of Investigator-Initiated Investigational New-Drug Trials for Unapproved Anticancer Drugs in Japan

Crossref DOI link: https://doi.org/10.1177/2168479017705155

Published Online: 2017-12-30

Published Print: 2017-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark